يعرض 121 - 140 نتائج من 28,722 نتيجة بحث عن '(( 5 ((mg decrease) OR (mean decrease)) ) OR ( 50 ((teer decrease) OR (a decrease)) ))', وقت الاستعلام: 0.74s تنقيح النتائج
  1. 121
  2. 122

    Temporal changes in IgE. حسب Hiromi Yamaguchi (2396248)

    منشور في 2022
    الموضوعات:
  3. 123
  4. 124
  5. 125

    IgG and age. حسب Hiromi Yamaguchi (2396248)

    منشور في 2022
    الموضوعات:
  6. 126
  7. 127

    Periodicity of IgE. حسب Hiromi Yamaguchi (2396248)

    منشور في 2022
    الموضوعات:
  8. 128
  9. 129
  10. 130

    Temporal changes in IgG. حسب Hiromi Yamaguchi (2396248)

    منشور في 2022
    الموضوعات:
  11. 131

    IgG periodicity. حسب Hiromi Yamaguchi (2396248)

    منشور في 2022
    الموضوعات:
  12. 132

    Table_1_Anti-Mitochondrial Antibody Titers Decrease Over Time in Primary Biliary Cholangitis Patients With Ursodeoxycholic Acid Therapeutic Response: A Cohort Study Followed Up to... حسب Ming-Ling Chang (44638)

    منشور في 2022
    "…Patients with baseline cirrhosis (2.78 ± 2.56 vs. 6.84 ± 9.00 mg/dL, p=0.024) and UDCA nonresponders (2.54 ± 2.19 vs. 4.51 ± 6.99 mg/dL, p=0.006) had increased total bilirubin levels while patients without cirrhosis (AST: 91.5 ± 84.5 vs. 58.9 ± 43.7 U/L, p<0.001; ALT: 107.3 ± 122.5 vs. 50.7 ± 36.8 U/L, p<0.001) and UDCA responders (AST: 83.8 ± 101.3 vs. 45.58 ± 38.42 U/L, p=0.014; ALT: 95.10 ± 144.6 vs. 39.12 ± 30.65 U/L, p=0.009) had decreased aminotransferase levels. …"
  13. 133

    Image_1_Anti-Mitochondrial Antibody Titers Decrease Over Time in Primary Biliary Cholangitis Patients With Ursodeoxycholic Acid Therapeutic Response: A Cohort Study Followed Up to... حسب Ming-Ling Chang (44638)

    منشور في 2022
    "…Patients with baseline cirrhosis (2.78 ± 2.56 vs. 6.84 ± 9.00 mg/dL, p=0.024) and UDCA nonresponders (2.54 ± 2.19 vs. 4.51 ± 6.99 mg/dL, p=0.006) had increased total bilirubin levels while patients without cirrhosis (AST: 91.5 ± 84.5 vs. 58.9 ± 43.7 U/L, p<0.001; ALT: 107.3 ± 122.5 vs. 50.7 ± 36.8 U/L, p<0.001) and UDCA responders (AST: 83.8 ± 101.3 vs. 45.58 ± 38.42 U/L, p=0.014; ALT: 95.10 ± 144.6 vs. 39.12 ± 30.65 U/L, p=0.009) had decreased aminotransferase levels. …"
  14. 134
  15. 135
  16. 136
  17. 137
  18. 138
  19. 139
  20. 140